Source:http://linkedlifedata.com/resource/pubmed/id/19362611
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-11-5
|
pubmed:abstractText |
Surrogate endpoints are biomarkers intended to substitute for a clinical endpoint. Are endoscopic ulcers a useful surrogate endpoint for a biological progression to clinical endpoints of ulcer complications (perforation, ulcers, and bleeds), hospital admission, or death?
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1542-7714
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1156-63
|
pubmed:meshHeading |
pubmed-meshheading:19362611-Biological Markers,
pubmed-meshheading:19362611-Clinical Trials as Topic,
pubmed-meshheading:19362611-Disease Progression,
pubmed-meshheading:19362611-Gastrointestinal Diseases,
pubmed-meshheading:19362611-Humans,
pubmed-meshheading:19362611-Prognosis,
pubmed-meshheading:19362611-Risk Assessment,
pubmed-meshheading:19362611-Ulcer
|
pubmed:year |
2009
|
pubmed:articleTitle |
Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm.
|
pubmed:affiliation |
Pain Research and Nuffield Department of Anaesthetics, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom. andrew.moore@nda.ox.ac.uk
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't
|